Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Refining Dynamic Risk Stratification and Prognostic Groups for Differentiated Thyroid Cancer With TERT Promoter Mutations
Tae Hyuk Kim, Chang‐Seok Ki, Hye Seung Kim, et al.
The Journal of Clinical Endocrinology & Metabolism (2017) Vol. 102, Iss. 5, pp. 1757-1764
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The American Association of Endocrine Surgeons Guidelines for the Definitive Surgical Management of Thyroid Disease in Adults
Kepal N. Patel, Linwah Yip, Carrie C. Lubitz, et al.
Annals of Surgery (2020) Vol. 271, Iss. 3, pp. e21-e93
Closed Access | Times Cited: 417
Risk Stratification in Differentiated Thyroid Cancer: From Detection to Final Follow-Up
R. Michael Tuttle, Ali S. Alzahrani
The Journal of Clinical Endocrinology & Metabolism (2019) Vol. 104, Iss. 9, pp. 4087-4100
Open Access | Times Cited: 130
Telomere Maintenance Mechanisms in Cancer
Tiago Bordeira Gaspar, Ana Sá, José Manuel Lopes, et al.
Genes (2018) Vol. 9, Iss. 5, pp. 241-241
Open Access | Times Cited: 113
Prognostic value of the eighth edition AJCC TNM classification for differentiated thyroid carcinoma
Tae Hyuk Kim, Young Nam Kim, Hye In Kim, et al.
Oral Oncology (2017) Vol. 71, pp. 81-86
Closed Access | Times Cited: 98
Thyroid Carcinoma: Phenotypic Features, Underlying Biology and Potential Relevance for Targeting Therapy
Jinwei Hu, Isabella J. Yuan, Saied Mirshahidi, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1950-1950
Open Access | Times Cited: 69
Association between TERT promoter mutations and clinical behaviors in differentiated thyroid carcinoma: a systematic review and meta-analysis
Jing Yang, Yanping Gong, Shuping Yan, et al.
Endocrine (2019) Vol. 67, Iss. 1, pp. 44-57
Open Access | Times Cited: 70
TERT promoter mutations identify a high-risk group in metastasis-free advanced thyroid carcinoma
Claire Bournaud, Françoise Descôtes, Myriam Decaussin‐Petrucci, et al.
European Journal of Cancer (2019) Vol. 108, pp. 41-49
Open Access | Times Cited: 50
Dynamic risk assessment in patients with differentiated thyroid cancer
Fabián Pitoia, Fernando Jerkovich
Endocrine Related Cancer (2019) Vol. 26, Iss. 10, pp. R553-R566
Open Access | Times Cited: 48
Practical Initial Risk Stratification Based on Lymph Node Metastases in Pediatric and Adolescent Differentiated Thyroid Cancer
Min Ji Jeon, Young Nam Kim, Tae-Yong Sung, et al.
Thyroid (2017) Vol. 28, Iss. 2, pp. 193-200
Closed Access | Times Cited: 47
<i>BRAF</i> and <i>TERT</i> promoter mutations: clinical application in thyroid cancer
Jae Hoon Chung
Endocrine Journal (2020) Vol. 67, Iss. 6, pp. 577-584
Open Access | Times Cited: 39
Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations
Hyunju Park, Hyeong Chan Shin, Heera Yang, et al.
Modern Pathology (2021) Vol. 35, Iss. 2, pp. 186-192
Open Access | Times Cited: 31
Molecular Pathology of Non-familial Follicular Epithelial–Derived Thyroid Cancer in Adults: From RAS/BRAF-like Tumor Designations to Molecular Risk Stratification
Paula Soares, Antónia Póvoa, Miguel Melo, et al.
Endocrine Pathology (2021) Vol. 32, Iss. 1, pp. 44-62
Closed Access | Times Cited: 28
The Influence of Glycolytic Enzyme Expression on the Aggressiveness of Papillary Thyroid Carcinoma Using TCGA Data
Won Woong Kim, Daham Kim, Jin Kyong Kim, et al.
Journal of Endocrine Surgery (2025) Vol. 25, Iss. 1, pp. 13-13
Closed Access
Active Surveillance for Papillary Thyroid Microcarcinoma: Challenges and Prospects
Shuai Xue, Peisong Wang, Zachary Hurst, et al.
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 26
Prognostic significance of TERT promoter and BRAF mutations in TIR-4 and TIR-5 thyroid cytology
Simona Censi, Susi Barollo, Elisabetta Grespan, et al.
European Journal of Endocrinology (2019) Vol. 181, Iss. 1, pp. 1-11
Open Access | Times Cited: 21
Thyroid carcinoma‐featured telomerase activation and telomere maintenance: Biology and translational/clinical significance
Xiaotian Yuan, Huiyang Yuan, Ning Zhang, et al.
Clinical and Translational Medicine (2022) Vol. 12, Iss. 11
Open Access | Times Cited: 11
Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part II. Follow-up Surveillance after Initial Treatment 2024
Mijin Kim, Ji-In Bang, Ho‐Cheol Kang, et al.
International Journal of Thyroidology (2024) Vol. 17, Iss. 1, pp. 115-146
Open Access | Times Cited: 2
An update on the status of molecular testing for the indeterminate thyroid nodule and risk stratification of differentiated thyroid cancer
Kristina J. Nicholson, Linwah Yip
Current Opinion in Oncology (2017) Vol. 30, Iss. 1, pp. 8-15
Closed Access | Times Cited: 21
Transcriptome analysis of papillary thyroid cancer harboring telomerase reverse transcriptase promoter mutation
Ming‐Nan Chien, Po‐Sheng Yang, Yi‐Chiung Hsu, et al.
Head & Neck (2018) Vol. 40, Iss. 11, pp. 2528-2537
Closed Access | Times Cited: 20
Long-Term Prognostic Value of the Response to Therapy Assessed by Laboratory and Imaging Findings in Patients with Differentiated Thyroid Cancer
Michele Klain, Emilia Zampella, Leandra Piscopo, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4338-4338
Open Access | Times Cited: 15
Fifty years of thyroid pathology: concepts and developments
Zubair Baloch, Virginia A. LiVolsi
Human Pathology (2019) Vol. 95, pp. 46-54
Closed Access | Times Cited: 17
Follow-up strategy of radiofrequency ablation for papillary thyroid microcarcinoma: defining a response-to-ablation system
Xinyang Li, Lin Yan, Jing Xiao, et al.
European Radiology (2023) Vol. 34, Iss. 2, pp. 761-769
Closed Access | Times Cited: 5
Telomerase reverse transcriptase promoter mutations in thyroid carcinomas: implications in precision oncology—a narrative review
Xiaotian Yuan, Tiantian Liu, Dawei Xu
Annals of Translational Medicine (2020) Vol. 8, Iss. 19, pp. 1244-1244
Open Access | Times Cited: 13
Proposal of a New Prognostic Model for Differentiated Thyroid Cancer with TERT Promoter Mutations
Jun Park, Sungjoo Lee, Jiyun Park, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 2943-2943
Open Access | Times Cited: 10
Suspicious ultrasound and clinicopathological features of papillary thyroid carcinoma predict the status of TERT promoter
Hui Shi, Le‐Hang Guo, Yifeng Zhang, et al.
Endocrine (2020) Vol. 68, Iss. 2, pp. 349-357
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top